Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical course. Bone Marrow Transplant 2003 Aug;32(3):287-91 PMID: 12858200

Pubmed ID



The purpose of this study was to evaluate if the tumor load, as determined by a real-time quantitative PCR (RQ-PCR) assay, correlated with the clinical course of follicular lymphoma patients after stem cell transplantation (SCT). Cryopreserved bone marrow and/or peripheral blood samples obtained at different time intervals after SCT from 11 patients (seven allogeneic, T-cell depleted/four autologous) were tested for tumor load, as defined by t(14;18) positive cells/total cells, using RQ-PCR. None of the six patients who remained in remission had samples with a tumor load >0.01% after SCT, although fluctuating tumor loads of </=0.01% were observed in three of these patients. In contrast, four of the five patients (three allogeneic/two autologous) with relapsed/progressive disease had increasing tumor loads of >0.01% after SCT (0/6 vs 4/5, P<0.02, Fisher's exact). Our results suggest that RQ-PCR measurable tumor load >0.01% after SCT may correlate with relapsed/progressive disease. Prospective studies with greater numbers of cases are indicated to better determine the critical tumor load that predicts poor outcome after SCT with RQ-PCR.

Author List

Chang CC, Bredeson C, Juckett M, Logan B, Keever-Taylor CA


Brent R. Logan PhD Director, Professor in the Institute for Health and Equity department at Medical College of Wisconsin


2-s2.0-0043171049   13 Citations

MESH terms used to index this publication - Major topics in bold

Disease Progression
Hematopoietic Stem Cell Transplantation
Lymphoma, Follicular
Middle Aged
Molecular Diagnostic Techniques
Neoplasm, Residual
Polymerase Chain Reaction
Retrospective Studies
Time Factors
Translocation, Genetic
jenkins-FCD Prod-321 98992d628744e349846c2f62ac68f241d7e1ea70